Export 14 results:
Author Title [ Type(Asc)] Year
Filters: Author is El Sahly, Hana M  [Clear All Filters]
Journal Article
M. J. Mulligan, Stapleton, J. T., Keitel, W. A., Frey, S. E., Chen, W. H., Rouphael, N., Edupuganti, S., Beck, A., Winokur, P. L., Sahly, H. M. El, Patel, S. M., Atmar, R. L., Graham, I., Anderson, E., El-Kamary, S. S., Pasetti, M. F., Sztein, M. B., Hill, H., and Goll, J. B., Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial., Vaccine, vol. 35, no. 36, pp. 4730-4737, 2017.
H. M. El Sahly, Atmar, R. L., Sendra, E., Wegel, A., and Keitel, W. A., Topical Imiquimod Does not Provide an Adjuvant Effect when Administered with Inactivated Influenza A/H5N1 Vaccine in Healthy Young Adults., J Infect Dis, vol. Online Ahead of Print, 2021.
H. M. El Sahly, Atmar, R. L., Patel, S. M., Bellamy, A., Liu, L., Hong, W., Zhu, H., Guan, Y., and Keitel, W. A., Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination., Vaccine, vol. 37, no. 19, pp. 2561-2568, 2019.
L. A. Jackson, Frey, S. E., Sahly, H. M. El, Mulligan, M. J., Winokur, P. L., Kotloff, K. L., Campbell, J. D., Atmar, R. L., Graham, I., Anderson, E. J., Anderson, E. L., Patel, S. M., Fields, C., Keitel, W., Rouphael, N., Hill, H., and Goll, J. B., Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial., Vaccine, vol. 35, no. 13, pp. 1675-1682, 2017.
D. I. Bernstein, Sahly, H. M. El, Keitel, W. A., Wolff, M., Simone, G., Segawa, C., Wong, S., Shelly, D., Young, N. S., and Dempsey, W., Safety and immunogenicity of a candidate parvovirus B19 vaccine., Vaccine, vol. 29, no. 43, pp. 7357-63, 2011.
W. A. Keitel, Piedra, P. A., Atmar, R. L., Demmler, G., Sahly, H. M. El, Barrett, J., Halpin, R. A., Lagos, R., Fisher-Hoch, S., and Munoz, F., Rapid research response to the 2009 A(H1N1)pdm09 influenza pandemic (Revised)., BMC Res Notes, vol. 6, p. 177, 2013.
L. A. Jackson, Sahly, H. M. El, George, S., Winokur, P., Edwards, K., Brady, R. C., Rouphael, N., Keitel, W. A., Mulligan, M. J., Burton, R. L., Nakamura, A., Ferreria, J., and Nahm, M. H., Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine., Vaccine, vol. 36, no. 5, pp. 606-614, 2018.
D. I. Bernstein, Jackson, L., Patel, S. M., Sahly, H. M. El, Spearman, P., Rouphael, N., Rudge, T. L., Hill, H., and Goll, J. B., Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults., Vaccine, vol. 32, no. 47, pp. 6284-93, 2014.
P. Winokur, Sahly, H. M. El, Mulligan, M. J., Frey, S. E., Rupp, R., Anderson, E. J., Edwards, K. M., Bernstein, D. I., Schmader, K., Jackson, L. A., Chen, W. H., Hill, H., and Bellamy, A., Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older., Vaccine, vol. S0264-410X, no. 20, pp. 31504-31508, 2021.
H. M. El Sahly, Davis, C., Kotloff, K., Meier, J., Winokur, P. L., Wald, A., Johnston, C., George, S. L., Brady, R. C., Lehmann, C., Stokes-Riner, A., and Keitel, W. A., Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial., J Infect Dis, vol. 205, no. 5, pp. 703-12, 2012.
H. M. El Sahly, Makedonas, G., Corry, D., Atmar, R. L., Bellamy, A., Cross, K., and Keitel, W. A., An evaluation of cytokine and cellular immune responses to heterologous prime-boost vaccination with influenza A/H7N7-A/H7N9 inactivated vaccine., Hum Vaccin Immunother, vol. 16, no. 12, pp. 3138-3145, 2020.
L. A. Jackson, Campbell, J. D., Frey, S. E., Edwards, K. M., Keitel, W. A., Kotloff, K. L., Berry, A. A., Graham, I., Atmar, R. L., C Creech, B., Thomsen, I. P., Patel, S. M., Gutierrez, A. F., Anderson, E. L., Sahly, H. M. El, Hill, H., Noah, D. L., and Bellamy, A. R., Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial., JAMA, vol. 314, no. 3, pp. 237-46, 2015.
S. M. Patel, Atmar, R. L., Sahly, H. M. El, Guo, K., Hill, H., and Keitel, W. A., Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes., J Infect Dis, vol. 206, no. 7, pp. 1069-77, 2012.
H. M. El Sahly, Gorchakov, R., Lai, L., Natrajan, M. S., Patel, S. M., Atmar, R. L., Keitel, W. A., Hoft, D. F., Barrett, J., Bailey, J., Edupuganti, S., Raabe, V., Wu, H. M., Fairley, J., Rouphael, N., Murray, K. O., and Mulligan, M. J., Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood., Open Forum Infect Dis, vol. 6, no. 1, p. ofy352, 2019.